ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.29
-1.75%
US Tech 100
19,954.80
0.37%
S&P 500
5,778.15
-1.22%
US Dollar vs CAD
1.44125
0.10%
Bitcoin
86,851.46
-0.43%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Accenture Plc (0Y0Y) Share Price

Accenture Plc

Accenture Plc (0Y0Y)

LSE
156.94
0.00
(0.00%)
Closed March 04 10:30AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
156.94
Bid
0.00
Ask
0.00
Volume
26,064
0.00 Day's Range 0.00
156.94 52 Week Range 156.94
Market Cap
105.457B
Previous Close
156.94
Open
-
Last Trade
20
@
346.42
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
3,990
Shares Outstanding
671,956,000
Dividend Yield
-
PE Ratio
31.98
Earnings Per Share (EPS)
10.81
Revenue
64.9B
Net Profit
7.26B

About Accenture Plc

Sector
Business Services, Nec
Industry
Business Services, Nec
Website
www.accenture.com
Headquarters
Dublin, Irl
Founded
-
Accenture Plc is listed in the Business Services sector of the London Stock Exchange with ticker 0Y0Y. The last closing price for Accenture was US$156.94. Over the last year, Accenture shares have traded in a share price range of US$ 156.94 to US$ 156.94.

Accenture currently has 671,956,000 shares outstanding. The market capitalization of Accenture is US$105.46 billion. Accenture has a price to earnings ratio (PE ratio) of 31.98.

Ask ADVFN Intelligence (AI)

0Y0Y Latest News

More News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
100156.94156.94156.943272156.94DE
400156.94156.94156.943547156.94DE
1200156.94156.94156.943990156.94DE
2600156.94156.94156.9411715156.94DE
5200156.94156.94156.948771156.94DE
15600156.94156.94156.9418628156.94DE
26000156.94156.94156.9412629156.94DE

0Y0Y - Frequently Asked Questions (FAQ)

What is the current Accenture share price?
The current share price of Accenture is US$ 156.94
How many Accenture shares are in issue?
Accenture has 671,956,000 shares in issue
What is the market cap of Accenture?
The market capitalisation of Accenture is USD 105.46B
What is the 1 year trading range for Accenture share price?
Accenture has traded in the range of US$ 156.94 to US$ 156.94 during the past year
What is the PE ratio of Accenture?
The price to earnings ratio of Accenture is 31.98
What is the cash to sales ratio of Accenture?
The cash to sales ratio of Accenture is 3.58
What is the reporting currency for Accenture?
Accenture reports financial results in USD
What is the latest annual turnover for Accenture?
The latest annual turnover of Accenture is USD 64.9B
What is the latest annual profit for Accenture?
The latest annual profit of Accenture is USD 7.26B
What is the registered address of Accenture?
The registered address for Accenture is 1 GRAND CANAL SQUARE, GRAND CANAL HARBOUR, DUBLIN
What is the Accenture website address?
The website address for Accenture is www.accenture.com
Which industry sector does Accenture operate in?
Accenture operates in the BUSINESS SERVICES, NEC sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ADMEAdm Energy Plc
0.35p
(59.09%)
9.76M
WSGWestminster Group Plc
1.40p
(27.27%)
3.23M
EUAEurasia Mining Plc
6.20p
(22.77%)
33.44M
WHRWarehouse Reit Plc
98.90p
(16.63%)
13.38M
MET1Metals One Plc
0.575p
(15.00%)
3.65M
BUCBuilt Cybernetics Plc
1.60p
(-81.18%)
520k
SAVESavannah Energy Plc
9.65p
(-63.24%)
238.56M
TIGTeam Internet Group Plc
54.30p
(-44.93%)
5.38M
VELAVela Technologies Plc
0.0029p
(-42.00%)
1.51B
ALBAAlba Mineral Resources
0.0135p
(-27.03%)
152.03M
VELAVela Technologies Plc
0.0029p
(-42.00%)
1.51B
TRPTower Resources Plc
0.023p
(-2.13%)
336.13M
CORCorpus Resources Plc
0.0145p
(3.57%)
267.93M
SAVESavannah Energy Plc
9.65p
(-63.24%)
238.56M
GWMOGreat Western Mining Corporation Plc
0.01p
(11.11%)
234.69M

Discussion

View Full Feed
jimr1717 jimr1717 2 minutes ago
Lmao look at the payroll. Shares to self enrich the insiders and Koolaide stand revenue.

“Back to Work”

No one is fooled

Absolutely No One
IFUS
Investor082 Investor082 2 minutes ago
The person who’s hurt NWBO is LP. The buck stops at her. She sits on her a**, doesn’t do biotech investor presentations, no business plan, endless dilution, no urgency, terrible web presence, lies, excuses, victim mindset, and the list goes on.
NWBO
getmenews getmenews 2 minutes ago
Yes, lets do discuss in more cryptic literal detail with congress tonight, one fact, your either with us, or against us...
XRPUSD
mikepgator mikepgator 3 minutes ago
Yes, there is a board for NWL Newell Brands, they own Elmers,
RDGL
jay_tee jay_tee 3 minutes ago
JMONEY!! I think LG is tryin to take your mantle of top clown! WTH?!! lol
RNVA
a surfer a surfer 3 minutes ago
Rebatarded
XRPUSD
WorstLuck WorstLuck 3 minutes ago
OCUL - mini quiz (easy)

During the Q4 conference call one of the analysts asked for an explanation of the 56 week endpoint in Sol-R, noting that the original presentation prior to final discussion with the FDA was at week 48. The explanation given on the call (starting around the 34:
OCUL
PEACHMAN PEACHMAN 4 minutes ago
Did you see the Agriglow owners and their families on tweets from India Dope

https://x.com/ImpactfusionI/status/1896603761055039670?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Etweet

https://x.com/ImpactfusionI/status/1896899799175282802

No one is ever
IFUS
DavidW2 DavidW2 4 minutes ago
NWBO might has best product but very poor communication with investors. Question I have is, how come investors can let it go on every ASM? No complaint? No question? No any PR news since July 2024, actually that PR was not a news at all, it just says passed the votes...
NWBO
Soapboxmom Soapboxmom 5 minutes ago
https://texasscorecard.com/state/texas-senators-consider-measure-in-committee-to-ban-all-thc-products/

Eddie "Vakscam" Vakser's Knockout products are about to be knocked out of his home state Texas if this moves forward. It appears local law enforcement right down the street from Va
AURI
getmenews getmenews 5 minutes ago
Monitor this, that, for what?

Your just a troll
XRPUSD
Truenorth2016 Truenorth2016 5 minutes ago
Lordy...getting pathetic indeed here at GCAN.
yes you are stalking him....do I need to Pull up the VIOLENT Post toward the CEO? I dont like how Target stop selling my favorite athletic attire, but im not on their message board attacking and subliminally attacking the CEO and trying to down p
GCAN
againstallodds againstallodds 5 minutes ago
Nope. Historical charts prove it

https://investorshub.advfn.com/uimage/uploads/2025/2/27/eyxxtIMG_0317.jpeg

https://investorshub.advfn.com/uimage/uploads/2020/10/23/fovmtIMG_0017.PNG
PDIV
jjjjjjjj jjjjjjjj 6 minutes ago
1.7M shares traded today. Yet the price got back up to $0.0003. Yes, the play is dead MJNA at $0.0002. It lasted one day only. There is no sellers but faked short settlement days. 902M shares are impressive. Make sure you lock up your shares from short sellers. I am still waiting for my retiremen
MJNA
mascale mascale 6 minutes ago
Back to waterchaser im-poster incapability: Comments with zero basis in recent data. " Even in the matter of the Preliminary Feasibility Study in Tasmania--that had been the outcome of a quiet process: Under way, under way, up and running--run, run, run! " Likely even Q4 can repeat itself--that
HIRU
stoxjock stoxjock 7 minutes ago
Thanks for your insight,,.. Whatever they need to do IF they 'Need to Hide The Sausage', as long as they pay me and my P, K & UQs with Equity for P, K & CASH$$$ for my UQ OR newly minted COOP shares for every Flavor of my WaMu Stock...
COOP
PEACHMAN PEACHMAN 7 minutes ago
IFUS has been working with Business owners in India since December 2023..can you even read dope

Why do you keep providing fake news about India

https://impactfusionbrands.com/2023/12/impact-fusion-international-signs-letter-of-intent-and-non-disclosure-with-agriglow-bio
IFUS
Niknak1 Niknak1 8 minutes ago
Jazzy and KGRO !! You two are the ones That need to take a DUMP.YOU BOTH MAKE NO SENSE. GO PLAY IN THE FREEWAY AT 5:00. CAN'T YOU FIND SOMETHING BETTER TO DO RATHER THAN JUST BASH BASH BASH.
CYDY
NotSure2 NotSure2 8 minutes ago
It depends on a lot of factors, same with FDA. MHRA can be 2 years if you look at the stats. Unfortunately everyone here always jump on the shortest timeframe (and promoting it) creating false hope that are picked up and wrongly believed by some youtuber...

Repeat this over and over a
NWBO
blackcat blackcat 8 minutes ago
Looks delightful. Hope they get the FAA fixed before traveling. I am currently boycotting airplanes!
JTORENCE JTORENCE 9 minutes ago
drugrunner And you know this how???

"an approval within 30 days and settlement $$ flowing before the EOY 2025 .."
NWBO
getmenews getmenews 9 minutes ago
Well put in a good word for yah
XRPUSD
Don Faton Don Faton 9 minutes ago
Yeah it's financials they dont and wont need to be audited.   Just. Need to be done and uploaded and accepted by the otciq and then tbr tier level will change to limited 
OPTI
Smitty5150 Smitty5150 10 minutes ago
https://www.sciencedirect.com/science/article/pii/S2452302X16300638

This might help you in your search for drug approval times for US FDA and EU EMA.
NWBO

Your Recent History

LSE
0Y0Y
Accenture
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads